T04.01.13 RISK OF INFECTIOUS COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH VEDOLIZUMAB: A REAL LIFE EXPERIENCE. (1st October 2020)